Critical Medicines Act EU seals deal on Critical Medicines Act after marathon talks After 12 hours of overnight negotiations, EU lawmakers reached a provisional agreement on the Critical Medicines Act aimed at boosting Europe’s pharmaceutical resilience
EU/US Trade US tariffs and MFN pricing threaten pharma investment and access in Europe Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe
